TBK1 and amyotrophic lateral sclerosis: While further studies are needed, it is likely that alterations in systemic immunity and microglial function will be present in ALS/FTD patients with loss of TBK1 function, and raises the possibility that like for other ALS/FTD genes, altered function of immune cells will contribute to disease pathogenesis.